Trials / Recruiting
RecruitingNCT06141447
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Changes in Rate of Hemorrhage With Prophylactic Oxytocin for Second Trimester Dilation and Evacuation in the Clinic Setting
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- Female
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin + normal saline | 40 units IV oxytocin once in a 1000 mL bag of normal saline |
| DRUG | Normal saline | 1000 mL bag of normal saline alone |
Timeline
- Start date
- 2024-05-02
- Primary completion
- 2026-11-02
- Completion
- 2026-11-02
- First posted
- 2023-11-21
- Last updated
- 2024-12-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06141447. Inclusion in this directory is not an endorsement.